Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
ESG Targets & Commitments
| Topic | Target / Metric | Status |
|---|---|---|
| Human Rights in Supply Chain | HR clauses in all contracts | Commitment |
AI Risk Summary
**Financial Risk Summary: Indoco Remedies Limited** Indoco faces critical compliance exposure with a maximum 10.0/10 compliance risk score and estimated remediation costs of ₹2–9 crore, primarily driven by undefined Extended Producer Responsibility (EPR) obligations under pharmaceutical waste regulations—a material 0.6% of annual revenue at the high end. The company's failure to disclose Scope 1 and 2 emissions despite manufacturing operations raises immediate SEBI BRSR Core Expansion non-compliance risk, potentially triggering enforcement action and delisting if reporting gaps persist in the next disclosure cycle. Water and GHG intensity risks (both 5.0/10) require urgent baseline establishment and mitigation roadmap; at India's carbon credit price of ₹600–900/tonne, unquantified emissions represent latent carbon liability. Priority actions: clarify EPR applicability and pharmaceutical waste disposal costs, establish emissions accounting framework, and ensure full BRSR P6 environmental disclosure compliance to mitigate regulatory and capital market penalties.
Source: Indoco Remedies Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.